Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
People Living with HIV in the COVID-19 Era: A Case Report.
Farinacci D, Ciccullo A, Borghetti A, Visconti E, Tamburrini E, Izzi IM, Cauda R, Di Giambenedetto S, Pallavicini F. Farinacci D, et al. AIDS Res Hum Retroviruses. 2021 Apr;37(4):253-254. doi: 10.1089/AID.2020.0149. Epub 2020 Sep 18. AIDS Res Hum Retroviruses. 2021. PMID: 32842754 No abstract available.
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV.
Ciccullo A, D'Angelillo A, Iannone V, Farinacci D, Lombardi F, Visconti E, Tamburrini E, Di Giambenedetto S. Ciccullo A, et al. Among authors: farinacci d, d angelillo a. J Acquir Immune Defic Syndr. 2021 Sep 1;88(1):e5-e6. doi: 10.1097/QAI.0000000000002730. J Acquir Immune Defic Syndr. 2021. PMID: 34397747 No abstract available.
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice.
Borghetti A, Farinacci D, Ciccullo A, Dusina A, Moschese D, Iannone V, D'Angelillo A, Lombardi F, Donne VD, Massaroni V, Visconti E, Tamburrini E, Di Giambenedetto S. Borghetti A, et al. Among authors: farinacci d, d angelillo a. J Med Virol. 2022 Oct;94(10):4970-4974. doi: 10.1002/jmv.27890. Epub 2022 Jun 9. J Med Virol. 2022. PMID: 35638227
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life.
Iannone V, Farinacci D, D'Angelillo A, Dusina A, Lamanna F, Passerotto R, Baldin G, Visconti E, Tamburrini E, Borghetti A, Di Giambenedetto S, Ciccullo A. Iannone V, et al. Among authors: farinacci d, d angelillo a. AIDS Res Hum Retroviruses. 2022 Nov;38(11):878-880. doi: 10.1089/AID.2022.0050. Epub 2022 Oct 19. AIDS Res Hum Retroviruses. 2022. PMID: 36166220
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV.
Ciccullo A, Baldin G, Borghi V, Cossu MV, Giacomelli A, Lagi F, Farinacci D, Iannone V, Passerotto RA, Capetti A, Sterrantino G, Mussini C, Antinori S, Di Giambenedetto S. Ciccullo A, et al. Among authors: farinacci d. J Antimicrob Chemother. 2022 Dec 23;78(1):117-121. doi: 10.1093/jac/dkac362. J Antimicrob Chemother. 2022. PMID: 36272137
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen.
Iannone V, Passerotto RA, Lamanna F, Steiner RJ, Lombardi F, Salvo PF, Dusina A, Farinacci D, Borghetti A, Di Giambenedetto S, Ciccullo A. Iannone V, et al. Among authors: farinacci d. Viruses. 2023 Apr 25;15(5):1046. doi: 10.3390/v15051046. Viruses. 2023. PMID: 37243133 Free PMC article.
34 results